Development of albuterol sulfate pMDI using HFO-1234ze. Human factors engineering considerations

Devices pMDI

resource : Poster

Development of albuterol sulfate pMDI using a low GWP propellant 1,3,3,3-tetrafluoropropene (HFO-1234ze) to match Ventolin^® HFA Inhaler: I. Human factors engineering considerations. Presented by Ross Errington (Head of Drug Product Development) and Lei Mao (Vice Chair of IPAC-RS).

We showcased the results of this study at RDD 2025. Fill out your details below to be sent the poster.

You may also like

Development of albuterol sulfate pMDI using HFO-1234ze. Human factors engineering considerations

Mapping the product design space: Understanding and controlling manufacturing variability in pMDIs

The transition to low GWP propellants in pMDIs – Increasing your probability of success using a collaborative approach